Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Adaptive Biotechnologies Corp.
DescriptionTest based on LymphoSIGHT technology platform which combines multiplexed PCR assays for sequencing immunoglobulin and T cell receptors
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect minimal residual disease (MRD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today